The Indian pharmaceutical market is showing welcome and early signs of pre-pandemic level activity, in terms of both physicians returning to clinics and medical representative visits, the management of the country's largest pharma firm, Sun Pharmaceutical Industries Ltd., has indicated.
The rebounding on-ground scenario is encouraging and comes after months of initial strain where physicians stayed away from their clinics and sales personnel were generally grounded amid the early phase of the pandemic-related local lock-down in India
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?